Related Experiment Videos
Positron emission tomography with 11C-methionine in hyperparathyroidism
P Hellman1, H Ahlström, M Bergström
1Department of Surgery, Uppsala University, Sweden.
Surgery
|December 1, 1994
Summary
Positron emission tomography (PET) successfully localized 80% of abnormal parathyroid glands in hyperparathyroidism patients. This novel imaging technique shows promise for preoperative parathyroid gland assessment.
Area of Science:
- Nuclear Medicine
- Endocrinology
- Surgical Oncology
Background:
- Positron emission tomography (PET) has not been previously evaluated for preoperative localization and functional characterization of parathyroid tissue in hyperparathyroidism.
- Hyperparathyroidism management often requires accurate localization of abnormal parathyroid glands.
Purpose of the Study:
- To evaluate the utility of PET for preoperative localization and functional characterization of parathyroid tissue in patients with hyperparathyroidism.
- To assess the accuracy of PET in identifying abnormal parathyroid glands, including in reoperation cases.
Main Methods:
- 23 patients with hyperparathyroidism underwent PET imaging using L-[methyl-11C]-methionine.
- Six patients were re-evaluated after Na2-ethylenediamine tetraacetic acid infusion to assess its effect on parathyroid uptake.
Main Results:
- PET successfully localized 80% of abnormal parathyroid glands (adenoma, hyperplasia, carcinoma).
- In reoperation cases, PET achieved 87% true-positive localization.
- Na2-ethylenediamine tetraacetic acid infusion did not enhance parathyroid uptake; PET showed lower uptake in surrounding tissues.
- Conventional imaging methods were complementary to PET, especially in reoperation scenarios.
Conclusions:
- PET imaging offers a novel approach for visualizing abnormal parathyroid glands in hyperparathyroidism.
- PET demonstrates significant potential for improving preoperative parathyroid gland localization and characterization.